With regard to the genetic sutdies, Wu et al. [27] for the first time investigated the association between osteocalcin gene polymorphism and prostate cancer risk, and concluded that the HindIII polymorphism was a suitable genetic marker of prostate cancer. This evidence concerns the gene BGLAP and prostate carcinoma.